Skip to main content

Proffitt & Goodson Inc

SEC CIK
0001123812
Latest filing
Jul 22, 2026

LCTX holding history

Lineage Cell Therapeutics, Inc. in every 13F filed by Proffitt & Goodson Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

LCTX overviewAll 13F holders of LCTXFull Q2 2026 holdings

Shares (Q3 2022)
0
Sold out in Q3 2022
Value
$0
% of portfolio
0.0%
Quarters held
1
Since Q2 2022
Holdings of LCTX by Proffitt & Goodson Inc, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q3 20220$00.0%−17−100.0%Sold outHolders
Q2 202217$00.0%+17NewHolders